Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |